Showing results (381-390 of 1,848) with videos related to
Sort By:
Pageof 185
Journal of Clinical Psychology|July 1, 1977
Assessment of alcoholics' moods at the beginning and end of a hospital treatment programE X Freed, E P Riley, P OrnsteinActa Orthopaedica Scandinavica|October 12, 2000
Radiostereometric analysis in hip revision surgery--optimal time for index examination: 6 patients revised with impacted allografts and cement followed weekly for 6 weeksE Ornstein, H Franzén, R Johnsson, et al.Clinical & Experimental Metastasis|August 4, 1999
Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancerD L Ornstein, J MacNab, K H CohnActa Orthopaedica Scandinavica|January 6, 2001
The Harrington reconstruction for advanced periacetabular metastatic destruction: good outcome in 32 patientsJ Nilsson, P Gustafson, P Fornander, et al.European Journal of Pharmacology|June 4, 1982
Snout contact fixation, climbing and gnawing during apomorphine stereotypy in rats from two substrainsH Szechtman, K Ornstein, P Teitelbaum, et al.Journal for Immunotherapy of Cancer|October 2, 2021
Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysisAlice Tzeng, Tony H Tzeng, Moshe C OrnsteinCurrent Opinion in Rheumatology|July 20, 2012
The complement system in pediatric systemic lupus erythematosus, atypical hemolytic uremic syndrome, and complocentric membranoglomerulopathiesBradley W Ornstein, John P Atkinson, Peter DensenInternational Journal of Oncology|October 16, 2018
[Corrigendum] Phospho‑valproic acid inhibits pancreatic cancer growth in mice: Enhanced efficacy by its formulation in poly‑(L)‑lactic acid‑poly(ethylene glycol) nanoparticlesGeorge Mattheolabakis, Ruixue Wang, Basil Rigas, et al.The Journal of Physiology|September 2, 2006
Resonance (approximately 10 Hz) of excitatory networks in motor cortex: effects of voltage-dependent ion channel blockersManuel A Castro-Alamancos, Pavlos Rigas, Yoshie Tawara-HirataOncogene|June 30, 2007
Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancerA C Rigas, C N Robson, N J CurtinPageof 185